DnaJ, also known as Heat Shock Protein 40 (HSP40), is a member of the heat shock protein family. These proteins play a crucial role in cellular processes by aiding in protein folding, transport, and assembly. The human recombinant form of DnaJ (HSP40) is a synthesized version of this protein, which is used in various research and therapeutic applications.
DnaJ (HSP40) proteins are characterized by the presence of a J-domain, which is essential for their function. The J-domain interacts with the ATPase domain of HSP70, another heat shock protein, to stimulate its activity. This interaction is vital for the protein’s role as a molecular chaperone, helping to prevent protein aggregation and assisting in the proper folding of nascent polypeptides .
HSP40 proteins are involved in several critical cellular processes, including:
The role of DnaJ (HSP40) in preventing protein aggregation is particularly significant in the context of neurodegenerative diseases. For instance, the isoform DNAJB6b has been shown to prevent tau aggregation in neuronal cells, which is a hallmark of Alzheimer’s disease . This makes HSP40 a potential target for therapeutic interventions in such conditions.
Recombinant HSP40 is used in a variety of research applications, including: